7 Einträge gefunden

1. Drug-induced liver injury at a tertiary care centre in Germany: Model for End-stage Liver Disease is the best predictor of outcome

   1. Reike-Kunze, Martin
   2. Zenouzi, Roman
   3. Hartl, Johannes
   4. Krech, Till
   5. Weidemann, Sören
   6. Sterneck, Martina
   7. Weiler-Normann, Christina

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Severe secondary sclerosing cholangitis as manifestation of a very rare underlying disease, Schwere sekundär sklerosierende Cholangitis als Manifestation einer sehr seltenen Grunderkrankung

   1. Zecher, Britta Franziska
   2. Zenouzi, Roman
   3. Lang, Melanie
   4. Karagiannis, Panagiotis
   5. Clauditz, Till
   6. Fischer, Lutz
   7. Sterneck, Martina

   2021 - Forschungsinformationssystem des UKE
3. Metamizole: An underrated agent causing severe idiosyncratic drug-induced liver injury

   1. Sebode, Marcial
   2. Reike-Kunze, Martin
   3. Weidemann, Sören
   4. Zenouzi, Roman
   5. Hartl, Johannes
   6. Peiseler, Moritz
   7. Liwinski, Timur

   2020 - Forschungsinformationssystem des UKE
4. Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis

   1. Abdulkarim, Mosaab
   2. Zenouzi, Roman
   3. Sebode, Marcial
   4. Schulz, Lisa
   5. Quaas, Alexander
   6. Lohse, Ansgar W
   7. Schramm, Christoph

   2019 - Forschungsinformationssystem des UKE
5. TNF-Producing Th1 Cells Are Selectively Expanded in Liver Infiltrates of Patients with Autoimmune Hepatitis

   1. Bovensiepen, Claudia S
   2. Schakat, Miriam
   3. Sebode, Marcial
   4. Zenouzi, Roman
   5. Hartl, Johannes
   6. Peiseler, Moritz
   7. Li, Jun

   2019 - Forschungsinformationssystem des UKE
6. Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis

   1. Hartl, Johannes
   2. Denzer, Ulrike Walburga
   3. Ehlken, Hanno
   4. Zenouzi, Roman
   5. Peiseler, Moritz
   6. Sebode, Marcial
   7. Hübener, Sina

   2016 - Forschungsinformationssystem des UKE
7. Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis

   1. Hartl, Johannes
   2. Ehlken, Hanno
   3. Weiler-Normann, Christina
   4. Sebode, Marcial
   5. Kreuels, Benno
   6. Pannicke, Nadine
   7. Zenouzi, Roman

   2015 - Forschungsinformationssystem des UKE